ArticleFrontiers in pharmacology2020

Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development.

Fu Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.